BackGreat Novel Therapeutics Biotech & Medicals Overview

Great Novel Therapeutics Biotech & Medicals Long Term Debt

Track Great Novel Therapeutics Biotech & Medicals's long-term debt ($2.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$2.88M
↓ 51.85% YoYΔ $-3.10M vs prior year quarter

Peer trimmed avg / median

Loading

Great Novel Therapeutics Biotech & Medicals Long Term Debt History

Loading

Great Novel Therapeutics Biotech & Medicals vs. peers: Long Term Debt Comparison

Loading

Great Novel Therapeutics Biotech & Medicals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Great Novel Therapeutics Biotech & Medicals (7427.TWO) FAQ

The latest long-term debt for 7427.TWO is $2.9M as of June 2026. That compares with $6M in the prior-year period — down 51.8% year over year. Investors often review this figure alongside Great Novel Therapeutics Biotech & Medicals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 7427.TWO's long-term debt moved from $6M to $2.9M — a 51.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Great Novel Therapeutics Biotech & Medicals's operating scale or balance-sheet position.

A long-term debt figure of $2.9M for 7427.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 7427.TWO's long-term debt ($2.9M), review year-over-year change from $6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Great Novel Therapeutics Biotech & Medicals's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.